Alnylam Gets VIP Status as the FDA Slaps Breakthrough Tag on Patisiran Post author:Sam Post published:November 19, 2017 Post category:BioPharma The company is weeks away from completing its rolling NDA for Patisiran. Source: BioSpace You Might Also Like OrbiMed To Raise $450 Million For Third Asia Life Science Fund March 2, 2017 Bristol-Myers Squibb's Stock Topples as Kidney Cancer Drug Flunks Phase III Study August 15, 2017 Pfizer Creates COO Role for CEO Ian Read's Rumored Successor November 13, 2017
